As per the research report, the size of the North America Collagen and Gelatin Market is valued at USD 2.05 billion in 2021 and estimated to be growing at a CAGR of 8.9%, to reach USD 3.14 billion by 2026 during the forecast period 2021 to 2026.
Gelatin is a translucent and brittle substance which is derived from collagen. It is used as a gelling agent in the food industry and in the production of various drugs. Collagen is the main protein in the connective tissues of animals. It makes up for about 35% of the total body protein content.
Increased prevalence of chronic diseases, rising geriatric population and the widespread use of gelatin and collagen in regenerative medicine is driving the market growth. Collagen is being used in various drugs and medical devices which in turn is driving the market growth. Collagen is also being used for wound healing which is stimulating the growth of the market. However, collagen obtained from bovine and porcine sources carry the risk of disease transmission which is acting as a restraint to the market growth.
This research report segmented and sub-segmented into the following categories:
The Collagen and Gelatin market was dominated by North America due to high number cases of diabetes and cardiovascular diseases.
Companies playing a dominant role in the North America Collagen and Gelatin Market profiled in this report are LifeSciences Holding Corporation (U.S.), Collagen Solutions plc (U.K.), Vornia Biomaterials, Ltd. (Ireland), Collagen Matrix, Inc. (U.S.), GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium), Royal DSM (Netherlands), Integra SYMATESE (France), and NuCollagen, LLC. (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Source
5.1.1 Introduction
5.1.2 Bovine
5.1.3 Porcine
5.1.4 Marine
5.1.5 Others
5.1.6 Y-o-Y Growth Analysis, By source
5.1.7 Market Attractiveness Analysis, By source
5.1.8 Market Share Analysis, By source
5.2 Application
5.2.1 Introduction
5.2.2 Orthopaedic applications
5.2.3 Wound care
5.2.4 Cardiovascular applications
5.2.5 others
5.2.6 Y-o-Y Growth Analysis, By application
5.2.7 Market Attractiveness Analysis, By application
5.2.8 Market Share Analysis, By application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By source
6.1.3.3 By application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By source
6.1.4.3 By application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By source
6.1.5.3 By application
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Integra Lifesciences Holdings Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Collagen Matrix, Inc.
8.3 Collagen Solutions PLC
8.4 Royal DSM
8.5 Vornia Biomaterials, Ltd.
8.6 Symatese
8.7 Nucollagen, LLC.
8.8 PB Gelatin
8.9 GELITA AG
8.10 Nitta Gelatin, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
